TreeWAS – Variant ID: rs11650066

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H35 Other retinal disorders	0.764	0.236	0.000
H35.8 Other specified retinal disorders	0.759	0.241	0.000
H35.3 Degeneration of macula and posterior pole	0.722	0.278	0.000
H35.5 Hereditary retinal dystrophy	0.697	0.302	0.000
H30-H36 Disorders of choroid and retina	0.687	0.313	0.000
H35.9 Retinal disorder, unspecified	0.674	0.326	0.000
H33 Retinal detachments and breaks	0.672	0.328	0.000
H33.0 Retinal detachment with retinal break	0.657	0.343	0.000
H33.4 Traction detachment of retina	0.638	0.362	0.000
H35.6 Retinal haemorrhage	0.619	0.381	0.000
H35.4 Peripheral retinal degeneration	0.590	0.410	0.000
H35.0 Background retinopathy and retinal vascular changes	0.568	0.432	0.000
H34 Retinal vascular occlusions	0.554	0.446	0.000
H31 Other disorders of choroid	0.552	0.448	0.000
H35.1 Retinopathy of prematurity	0.547	0.452	0.000
H35.2 Other proliferative retinopathy	0.542	0.458	0.000
H35.7 Separation of retinal layers	0.498	0.502	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.492	0.507	0.000
H34.8 Other retinal vascular occlusions	0.492	0.508	0.000
H33.2 Serous retinal detachment	0.487	0.513	0.000
H33.5 Other retinal detachments	0.482	0.518	0.000
H31.8 Other specified disorders of choroid	0.474	0.526	0.000
H34.1 Central retinal artery occlusion	0.441	0.559	0.000
H30 Chorioretinal inflammation	0.427	0.572	0.000
H31.3 Choroidal haemorrhage and rupture	0.423	0.577	0.000
H33.1 Retinoschisis and retinal cysts	0.410	0.590	0.000
H31.9 Disorder of choroid, unspecified	0.403	0.597	0.000
H34.0 Transient retinal artery occlusion	0.397	0.603	0.000
H31.4 Choroidal detachment	0.396	0.604	0.000
H31.2 Hereditary choroidal dystrophy	0.396	0.604	0.000
H36 Retinal disorders in diseases classified elsewhere	0.373	0.627	0.000
H31.0 Chorioretinal scars	0.369	0.631	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.353	0.647	0.000
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.353	0.647	0.000
H31.1 Choroidal degeneration	0.340	0.660	0.000
H34.9 Retinal vascular occlusion, unspecified	0.339	0.661	0.000
H34.2 Other retinal artery occlusions	0.312	0.688	0.000
H30.8 Other chorioretinal inflammations	0.306	0.693	0.000
H30.2 Posterior cyclitis	0.306	0.693	0.000
H30.1 Disseminated chorioretinal inflammation	0.306	0.693	0.000
H30.0 Focal chorioretinal inflammation	0.306	0.693	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.268	0.732	0.000
H30.9 Chorioretinal inflammation, unspecified	0.241	0.758	0.000
H36.0 Diabetic retinopathy	0.149	0.851	0.000
H33.3 Retinal breaks without detachment	0.121	0.879	0.000
T42.4 Benzodiazepines	0.000	0.939	0.061
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.940	0.060
T42.1 Iminostilbenes	0.000	0.946	0.054
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.947	0.053
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.950	0.049
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.951	0.049
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.951	0.049
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.952	0.048
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.952	0.048
T42.0 Hydantoin derivatives	0.000	0.954	0.046
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.955	0.045
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.955	0.045
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.957	0.043
T42.3 Barbiturates	0.000	0.957	0.043
T42.2 Succinimides and oxazolidinediones	0.000	0.957	0.043
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.958	0.042
T46.1 Calcium-channel blockers	0.000	0.961	0.039
T50.4 Drugs affecting uric acid metabolism	0.000	0.962	0.038
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.962	0.038
S52.60 Fracture of lower end of both ulna and radius (closed)	0.000	0.962	0.038
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.962	0.038
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.962	0.038
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.964	0.036
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.964	0.036
T46.7 Peripheral vasodilators	0.000	0.964	0.036
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.964	0.036
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.964	0.036
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.965	0.035
T50.7 Analeptics and opioid receptor antagonists	0.000	0.965	0.035
T50.5 Appetite depressants	0.000	0.965	0.035
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.965	0.035
T50.1 Loop [high-ceiling] diuretics	0.000	0.965	0.035
T50.0 Mineralocorticoids and their antagonists	0.000	0.965	0.035
T50.8 Diagnostic agents	0.000	0.965	0.035
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.965	0.035
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.965	0.034
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.967	0.033
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.967	0.033
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.967	0.033
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.967	0.033
T36 Poisoning by systemic antibiotics	0.000	0.967	0.033
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.968	0.032
T43.6 Psychostimulants with abuse potential	0.000	0.969	0.031
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.969	0.031
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.970	0.030
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.972	0.028
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.972	0.028
T43.9 Psychotropic drug, unspecified	0.000	0.972	0.028
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.972	0.028
T48.5 Anti-common-cold drugs	0.000	0.973	0.027
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.973	0.027
T48.4 Expectorants	0.000	0.973	0.027
T48.3 Antitussives	0.000	0.973	0.027
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.973	0.027
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.973	0.027
T48.0 Oxytocic drugs	0.000	0.973	0.027
T43.2 Other and unspecified antidepressants	0.000	0.974	0.026
T36.0 Penicillins	0.000	0.974	0.026
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.975	0.025
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.975	0.025
T41.5 Therapeutic gases	0.000	0.975	0.025
T41.4 Anaesthetic, unspecified	0.000	0.975	0.025
T41.3 Local anaesthetics	0.000	0.975	0.025
T41.2 Other and unspecified general anaesthetics	0.000	0.975	0.025
T41.1 Intravenous anaesthetics	0.000	0.975	0.025
T41.0 Inhaled anaesthetics	0.000	0.975	0.025
T49.9 Topical agent, unspecified	0.000	0.975	0.025
T49.8 Other topical agents	0.000	0.975	0.025
T49.7 Dental drugs, topically applied	0.000	0.975	0.025
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.975	0.025
T49.5 Ophthalmological drugs and preparations	0.000	0.975	0.025
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.975	0.025
T49.3 Emollients, demulcents and protectants	0.000	0.975	0.025
T49.2 Local astringents and local detergents	0.000	0.975	0.025
T49.1 Antipruritics	0.000	0.975	0.025
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.975	0.025
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.976	0.024
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.976	0.024
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.976	0.024
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.976	0.024
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.976	0.024
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.976	0.024
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.976	0.024
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.976	0.024
T44.0 Anticholinesterase agents	0.000	0.976	0.024
T36.9 Systemic antibiotic, unspecified	0.000	0.976	0.023
T36.8 Other systemic antibiotics	0.000	0.976	0.023
T36.7 Antifungal antibiotics, systemically used	0.000	0.976	0.023
T36.6 Rifamycins	0.000	0.976	0.023
T36.5 Aminoglycosides	0.000	0.976	0.023
T36.2 Chloramphenicol group	0.000	0.976	0.023
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.976	0.023
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.976	0.023
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.977	0.023
T37.5 Antiviral drugs	0.000	0.977	0.023
T37.4 Anthelminthics	0.000	0.977	0.023
T37.3 Other antiprotozoal drugs	0.000	0.977	0.023
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.977	0.023
T37.1 Antimycobacterial drugs	0.000	0.977	0.023
T37.0 Sulphonamides	0.000	0.977	0.023
S52.6 Fracture of lower end of both ulna and radius	0.000	0.978	0.022
T36.4 Tetracyclines	0.000	0.978	0.022
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.978	0.022
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.979	0.020
T36.3 Macrolides	0.000	0.979	0.020
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.981	0.019
S52.61 Fracture of lower end of both ulna and radius (open)	0.000	0.981	0.019
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.982	0.018
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.982	0.018
T47.7 Emetics	0.000	0.982	0.018
T47.6 Antidiarrhoeal drugs	0.000	0.982	0.018
T47.5 Digestants	0.000	0.982	0.018
T47.3 Saline and osmotic laxatives	0.000	0.982	0.018
T47.2 Stimulant laxatives	0.000	0.982	0.018
T47.0 Histamine H(2)-receptor antagonists	0.000	0.982	0.018
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.982	0.018
T45.2 Vitamins, not elsewhere classified	0.000	0.982	0.018
T39.4 Antirheumatics, not elsewhere classified	0.000	0.983	0.017
T39.2 Pyrazolone derivatives	0.000	0.983	0.017
M47.87 Other spondylosis (Lumbosacral region)	0.017	0.983	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.983	0.017
T45.8 Other primarily systemic and haematological agents	0.000	0.983	0.017
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.983	0.017
T45.6 Fibrinolysis-affecting drugs	0.000	0.983	0.017
T45.4 Iron and its compounds	0.000	0.983	0.017
T45.3 Enzymes, not elsewhere classified	0.000	0.983	0.017
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.984	0.016
T47.4 Other laxatives	0.000	0.984	0.016
T39.0 Salicylates	0.000	0.984	0.016
T40.5 Cocaine	0.000	0.985	0.015
T45.0 Antiallergic and antiemetic drugs	0.000	0.985	0.014
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.986	0.014
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.986	0.014
T40.8 Lysergide [LSD]	0.000	0.986	0.014
T40.7 Cannabis (derivatives)	0.000	0.986	0.014
T40.3 Methadone	0.000	0.986	0.014
T40.1 Heroin	0.000	0.986	0.014
T40.0 Opium	0.000	0.986	0.014
T45.5 Anticoagulants	0.000	0.986	0.014
T39.1 4-Aminophenol derivatives	0.000	0.986	0.014
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.986	0.013
T38.9 Other and unspecified hormone antagonists	0.000	0.987	0.013
T38.7 Androgens and anabolic congeners	0.000	0.987	0.013
T38.5 Other oestrogens and progestogens	0.000	0.987	0.013
T38.4 Oral contraceptives	0.000	0.987	0.013
T38.2 Antithyroid drugs	0.000	0.987	0.013
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.987	0.013
T40.6 Other and unspecified narcotics	0.000	0.987	0.013
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.988	0.012
T38.1 Thyroid hormones and substitutes	0.000	0.988	0.012
H10 Conjunctivitis	0.012	0.988	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.988	0.012
H10-H13 Disorders of conjunctiva	0.012	0.988	0.000
Chapter VII Diseases of the eye and adnexa	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.000	0.989	0.011
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.989	0.011
H10.9 Conjunctivitis, unspecified	0.011	0.989	0.000
T38.0 Glucocorticoids and synthetic analogues	0.000	0.989	0.011
H10.8 Other conjunctivitis	0.011	0.989	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.001	0.989	0.010
H10.0 Mucopurulent conjunctivitis	0.011	0.989	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.010	0.990	0.000
H46 Optic neuritis	0.010	0.990	0.000
H11 Other disorders of conjunctiva	0.009	0.991	0.000
H10.5 Blepharoconjunctivitis	0.009	0.991	0.000
H10.3 Acute conjunctivitis, unspecified	0.009	0.991	0.000
H10.2 Other acute conjunctivitis	0.009	0.991	0.000
H10.1 Acute atopic conjunctivitis	0.009	0.991	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.000	0.991	0.009
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.009	0.991	0.000
Q61.2 Polycystic kidney, adult type	0.009	0.991	0.000
H13 Disorders of conjunctiva in diseases classified elsewhere	0.008	0.991	0.000
L85.8 Other specified epidermal thickening	0.008	0.992	0.000
H55-H59 Other disorders of eye and adnexa	0.008	0.992	0.000
H10.4 Chronic conjunctivitis	0.008	0.992	0.000
H11.0 Pterygium	0.008	0.992	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.007	0.992	0.000
L85.9 Epidermal thickening, unspecified	0.008	0.992	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.007	0.993	0.000
H11.8 Other specified disorders of conjunctiva	0.007	0.993	0.000
H11.2 Conjunctival scars	0.007	0.993	0.000
H11.3 Conjunctival haemorrhage	0.007	0.993	0.000
L85 Other epidermal thickening	0.007	0.993	0.000
H11.1 Conjunctival degenerations and deposits	0.007	0.993	0.000
H55 Nystagmus and other irregular eye movements	0.007	0.993	0.000
H57 Other disorders of eye and adnexa	0.007	0.993	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.007	0.993	0.000
Y42.7 Androgens and anabolic congeners	0.007	0.993	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.007	0.993	0.000
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.006	0.994	0.000
H13.2 Conjunctivitis in other diseases classified elsewhere	0.006	0.994	0.000
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.006	0.994	0.000
H13.0 Filarial infection of conjunctiva	0.006	0.994	0.000
Q61 Cystic kidney disease	0.006	0.994	0.000
H13.3 Ocular pemphigoid	0.006	0.994	0.000
H27.0 Aphakia	0.006	0.994	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.006	0.994	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.006	0.994	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
H25-H28 Disorders of lens	0.006	0.994	0.000
H57.1 Ocular pain	0.006	0.994	0.000
Q61.3 Polycystic kidney, unspecified	0.006	0.994	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.006	0.994	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.005	0.994	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.005	0.994	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.005	0.994	0.000
H27 Other disorders of lens	0.006	0.994	0.000
Y42.1 Thyroid hormones and substitutes	0.005	0.994	0.000
K29.3 Chronic superficial gastritis	0.006	0.994	0.000
L27 Dermatitis due to substances taken internally	0.000	0.995	0.005
Y42.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
L85.3 Xerosis cutis	0.005	0.995	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.005	0.995	0.000
L85.0 Acquired ichthyosis	0.005	0.995	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.005	0.995	0.000
N97.9 Female infertility, unspecified	0.005	0.995	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.005	0.995	0.000
T40.2 Other opioids	0.000	0.995	0.005
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.005	0.995	0.000
L27.1 Localised skin eruption due to drugs and medicaments	0.000	0.995	0.005
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.000	0.995	0.005
Q61.9 Cystic kidney disease, unspecified	0.005	0.995	0.000
H40-H42 Glaucoma	0.005	0.995	0.000
H51 Other disorders of binocular movement	0.005	0.995	0.000
H57.8 Other specified disorders of eye and adnexa	0.005	0.995	0.000
R23.4 Changes in skin texture	0.000	0.995	0.005
H51.2 Internuclear ophthalmoplegia	0.005	0.995	0.000
Y42.4 Oral contraceptives	0.005	0.995	0.000
H47.2 Optic atrophy	0.005	0.995	0.000
I67.2 Cerebral atherosclerosis	0.000	0.995	0.005
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.005	0.995	0.000
C44.6 Skin of upper limb, including shoulder	0.005	0.995	0.000
H11.9 Disorder of conjunctiva, unspecified	0.005	0.995	0.000
N94.1 Dyspareunia	0.000	0.995	0.005
Q61.8 Other cystic kidney diseases	0.005	0.995	0.000
Q61.1 Polycystic kidney, infantile type	0.005	0.995	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.005	0.995	0.000
Q61.4 Renal dysplasia	0.005	0.995	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.005	0.995	0.000
H47.7 Disorder of visual pathways, unspecified	0.005	0.995	0.000
H47.6 Disorders of visual cortex	0.005	0.995	0.000
H47.5 Disorders of other visual pathways	0.005	0.995	0.000
H47.4 Disorders of optic chiasm	0.005	0.995	0.000
G06.0 Intracranial abscess and granuloma	0.005	0.995	0.000
H27.1 Dislocation of lens	0.005	0.995	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.004	0.995	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.004	0.996	0.000
Q61.5 Medullary cystic kidney	0.004	0.996	0.000
G06.2 Extradural and subdural abscess, unspecified	0.004	0.996	0.000
H27.9 Disorder of lens, unspecified	0.004	0.996	0.000
H47.1 Papilloedema, unspecified	0.004	0.996	0.000
M47.89 Other spondylosis (Site unspecified)	0.004	0.996	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.996	0.004
Y42.5 Other oestrogens and progestogens	0.004	0.996	0.000
L27.9 Dermatitis due to unspecified substance taken internally	0.000	0.996	0.004
L27.8 Dermatitis due to other substances taken internally	0.000	0.996	0.004
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.996	0.004
H57.0 Anomalies of pupillary function	0.004	0.996	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.004	0.996	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.004	0.996	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.004	0.996	0.000
H59.0 Vitreous syndrome following cataract surgery	0.004	0.996	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.996	0.004
G00-G09 Inflammatory diseases of the central nervous system	0.004	0.996	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.996	0.004
H42 Glaucoma in diseases classified elsewhere	0.004	0.996	0.000
H28.0 Diabetic cataract	0.004	0.996	0.000
G06.1 Intraspinal abscess and granuloma	0.004	0.996	0.000
H51.9 Disorder of binocular movement, unspecified	0.004	0.996	0.000
H51.8 Other specified disorders of binocular movement	0.004	0.996	0.000
H51.1 Convergence insufficiency and excess	0.004	0.996	0.000
H51.0 Palsy of conjugate gaze	0.004	0.996	0.000
G00 Bacterial meningitis, not elsewhere classified	0.004	0.996	0.000
H49 Paralytic strabismus	0.004	0.996	0.000
H28.8 Other disorders of lens in diseases classified elsewhere	0.003	0.996	0.000
H28.2 Cataract in other diseases classified elsewhere	0.003	0.996	0.000
H28.1 Cataract in other endocrine, nutritional and metabolic diseases	0.003	0.996	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.004	0.996	0.000
G00.1 Pneumococcal meningitis	0.004	0.996	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.000	0.996	0.004
G04 Encephalitis, myelitis and encephalomyelitis	0.004	0.996	0.000
H47.3 Other disorders of optic disk	0.003	0.996	0.000
H26.2 Complicated cataract	0.004	0.996	0.000
H43-H45 Disorders of vitreous body and globe	0.003	0.996	0.000
Q61.0 Congenital single renal cyst	0.003	0.996	0.000
M54.56 Low back pain (Lumbar region)	0.003	0.997	0.000
H53-H54 Visual disturbances and blindness	0.003	0.997	0.000
H49.2 Sixth [abducent] nerve palsy	0.003	0.997	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.003	0.997	0.000
G00.2 Streptococcal meningitis	0.003	0.997	0.000
L27.2 Dermatitis due to ingested food	0.000	0.997	0.003
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.003	0.997	0.000
Q60-Q64 Congenital malformations of the urinary system	0.003	0.997	0.000
M47.8 Other spondylosis	0.003	0.997	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.003	0.997	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.997	0.003
J92.9 Pleural plaque without asbestos	0.000	0.997	0.003
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.003	0.997	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.003	0.997	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.997	0.003
R23 Other skin changes	0.000	0.997	0.003
H42.8 Glaucoma in other diseases classified elsewhere	0.003	0.997	0.000
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
H49.8 Other paralytic strabismus	0.003	0.997	0.000
T78.2 Anaphylactic shock, unspecified	0.003	0.997	0.000
R23.1 Pallor	0.000	0.997	0.003
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.003	0.997	0.000
S52 Fracture of forearm	0.000	0.997	0.003
M47.83 Other spondylosis (Cervicothoracic region)	0.003	0.997	0.000
H53.0 Amblyopia ex anopsia	0.003	0.997	0.000
G03 Meningitis due to other and unspecified causes	0.003	0.997	0.000
G00.8 Other bacterial meningitis	0.003	0.997	0.000
G00.3 Staphylococcal meningitis	0.003	0.997	0.000
G00.0 Haemophilus meningitis	0.003	0.997	0.000
R61.0 Localised hyperhidrosis	0.000	0.997	0.003
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.003	0.997	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.003	0.997	0.000
H27.8 Other specified disorders of lens	0.003	0.997	0.000
H49.3 Total (external) ophthalmoplegia	0.003	0.997	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.003	0.997	0.000
G04.1 Tropical spastic paraplegia	0.003	0.997	0.000
G04.0 Acute disseminated encephalitis	0.003	0.997	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.003	0.997	0.000
H50 Other strabismus	0.003	0.997	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.997	0.003
Q64 Other congenital malformations of urinary system	0.003	0.997	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.003	0.997	0.000
R61 Hyperhidrosis	0.000	0.997	0.003
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.997	0.003
N20.9 Urinary calculus, unspecified	0.000	0.997	0.003
Q62.2 Congenital megaloureter	0.003	0.997	0.000
H17.9 Corneal scar and opacity, unspecified	0.003	0.997	0.000
S52.3 Fracture of shaft of radius	0.000	0.997	0.003
R23.0 Cyanosis	0.000	0.997	0.003
H17 Corneal scars and opacities	0.003	0.997	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.003	0.997	0.000
H49.4 Progressive external ophthalmoplegia	0.002	0.997	0.000
H49.1 Fourth [trochlear] nerve palsy	0.003	0.997	0.000
Q62.8 Other congenital malformations of ureter	0.003	0.997	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
G00.9 Bacterial meningitis, unspecified	0.003	0.997	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.003	0.997	0.000
G03.0 Nonpyogenic meningitis	0.003	0.997	0.000
H49.9 Paralytic strabismus, unspecified	0.003	0.997	0.000
J20.9 Acute bronchitis, unspecified	0.003	0.997	0.000
S52.2 Fracture of shaft of ulna	0.000	0.997	0.003
Z54.0 Convalescence following surgery	0.000	0.997	0.003
Z58.1 Exposure to air pollution	0.003	0.997	0.000
I67 Other cerebrovascular diseases	0.000	0.997	0.003
F50.0 Anorexia nervosa	0.000	0.997	0.003
R22.0 Localised swelling, mass and lump, head	0.000	0.997	0.003
R23.8 Other and unspecified skin changes	0.000	0.997	0.003
T51.9 Alcohol, unspecified	0.000	0.997	0.003
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
H26 Other cataract	0.003	0.997	0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.002	0.997	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.002	0.997	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.002	0.997	0.000
H50.3 Intermittent heterotropia	0.002	0.997	0.000
Q64.4 Malformation of urachus	0.002	0.997	0.000
Q63 Other congenital malformations of kidney	0.002	0.997	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.002	0.997	0.000
S52.30 Fracture of shaft of radius (closed)	0.000	0.997	0.002
Q62.7 Congenital vesico-uretero-renal reflux	0.002	0.997	0.000
Q62.6 Malposition of ureter	0.002	0.997	0.000
Q62.4 Agenesis of ureter	0.002	0.997	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.002	0.997	0.000
Q62.1 Atresia and stenosis of ureter	0.002	0.997	0.000
Q62.0 Congenital hydronephrosis	0.002	0.997	0.000
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
Q62.5 Duplication of ureter	0.002	0.998	0.000
G03.8 Meningitis due to other specified causes	0.002	0.998	0.000
G03.2 Benign recurrent meningitis [Mollaret]	0.002	0.998	0.000
G03.1 Chronic meningitis	0.002	0.998	0.000
S60.9 Superficial injury of wrist and hand, unspecified	0.000	0.998	0.002
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.002	0.998	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.002	0.998	0.000
H50.8 Other specified strabismus	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.002	0.998	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.998	0.002
H50.4 Other and unspecified heterotropia	0.002	0.998	0.000
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.998	0.002
S52.20 Fracture of shaft of ulna (closed)	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
G02.1 Meningitis in mycoses	0.002	0.998	0.000
S52.7 Multiple fractures of forearm	0.000	0.998	0.002
F05.9 Delirium, unspecified	0.000	0.998	0.002
H26.3 Drug-induced cataract	0.002	0.998	0.000
H50.5 Heterophoria	0.002	0.998	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.998	0.002
I65.2 Occlusion and stenosis of carotid artery	0.002	0.998	0.000
S52.9 Fracture of forearm, part unspecified	0.000	0.998	0.002
H49.0 Third [oculomotor] nerve palsy	0.002	0.998	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.000	0.998	0.002
Q64.9 Congenital malformation of urinary system, unspecified	0.002	0.998	0.000
Q64.8 Other specified congenital malformations of urinary system	0.002	0.998	0.000
Q64.6 Congenital diverticulum of bladder	0.002	0.998	0.000
Q64.5 Congenital absence of bladder and urethra	0.002	0.998	0.000
Q64.2 Congenital posterior urethral valves	0.002	0.998	0.000
Q64.1 Exstrophy of urinary bladder	0.002	0.998	0.000
Q64.0 Epispadias	0.002	0.998	0.000
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.002	0.998	0.000
R61.1 Generalised hyperhidrosis	0.000	0.998	0.002
S52.4 Fracture of shafts of both ulna and radius	0.000	0.998	0.002
H17.8 Other corneal scars and opacities	0.002	0.998	0.000
S52.31 Fracture of shaft of radius (open)	0.000	0.998	0.002
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.998	0.002
H17.1 Other central corneal opacity	0.002	0.998	0.000
H17.0 Adherent leukoma	0.002	0.998	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.002	0.998	0.000
R23.3 Spontaneous ecchymoses	0.000	0.998	0.002
S52.1 Fracture of upper end of radius	0.000	0.998	0.002
Z58.8 Other problems related to physical environment	0.002	0.998	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.998	0.002
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.998	0.002
I67.5 Moyamoya disease	0.000	0.998	0.002
I67.4 Hypertensive encephalopathy	0.000	0.998	0.002
I67.3 Progressive vascular leukoencephalopathy	0.000	0.998	0.002
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.998	0.002
S52.8 Fracture of other parts of forearm	0.000	0.998	0.002
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
Q63.8 Other specified congenital malformations of kidney	0.002	0.998	0.000
Q63.3 Hyperplastic and giant kidney	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.002	0.998	0.000
H50.1 Divergent concomitant strabismus	0.002	0.998	0.000
R73 Elevated blood glucose level	0.000	0.998	0.002
S52.21 Fracture of shaft of ulna (open)	0.000	0.998	0.002
Q63.2 Ectopic kidney	0.002	0.998	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
K81.0 Acute cholecystitis	0.000	0.998	0.002
N97 Female infertility	0.002	0.998	0.000
G03.9 Meningitis, unspecified	0.002	0.998	0.000
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.002	0.998	0.000
H15 Disorders of sclera	0.002	0.998	0.000
S52.70 Multiple fractures of forearm (closed)	0.000	0.998	0.002
Q63.1 Lobulated, fused and horseshoe kidney	0.002	0.998	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.002	0.998	0.000
K04.8 Radicular cyst	0.000	0.998	0.002
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.998	0.002
Z75.2 Other waiting period for investigation and treatment	0.000	0.998	0.002
K14.9 Disease of tongue, unspecified	0.002	0.998	0.000
S52.91 Fracture of forearm, part unspecified (open)	0.000	0.998	0.002
N76.0 Acute vaginitis	0.002	0.998	0.000
M47.84 Other spondylosis (Thoracic region)	0.001	0.998	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.002	0.998	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.002	0.998	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations